Submit Paper

Article Processing Fee

Pay Online

           

Crossref logo

  DOI Prefix   10.20431


 

ARC Journal of Nutrition and Growth
Volume-4 Issue-1, 2018, Page No: 18-22

Maternal Thyroid Hormones and Neonatal Appetite

Ahmed R.G

Division of Anatomy and Embryology, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.

Citation : Ahmed R.G, "Maternal Thyroid Hormones and Neonatal Appetite" ARC Journal of Nutrition and Growth . 2018; 4(1) : 18-22.

Copyright : © 2018 Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Keywords: Maternal Thyroid,Hormones,Neonatal Appetite,Nutrition and Growth


Commentary


Fundamental actions of maternal thyroid hormones (THs) during the gestation are required for a normal fetal and neonatal development and growth (El-bakry et al., 2010; Ahmed, 2011, 2012a,b, 2013, 2014, 2015a-c, 2016a-d, 2017a-u & 2018a,b; Ahmed et al., 2010, 2013a,b, 2014, 2015a,b &2018a,b; Ahmed and Incerpi, 2013;Van Hercket al., 2013; Ahmed and El-Gareib, 2014,Incerpi et al., 2014; Candelotti et al., 2015; De Vito et al., 2015; El-Ghareeb et al., 2016; Ahmed and El-Gareib, 2017; Moog et al., 2017) in particular the energy, food intake, thermogenesis, body weight, metabolism of inorganic ions and nutrient, and metabolic rate and energy (Wolf et al., 1996;Ogilvy-Stuart, 2002; Manji et al., 2006; A min et al., 2011; Ahmed, 2013; Männistö et al., 2013). In addition, the balance in the hypothalamic-pituitary-thyroid axis (HPTA) has necessary roles for the critical developmental and functional periods(regulation of appetite and energy expenditure) (Ahmed et al., 2008; Ahmed and El-Gareib, 2017).The signaling of this axis [hypothalamic thyrotropin-releasing hormone (TRH), thyroid-stimulating hormone (TSH), 3,5,3'-triiodothyronine(T3) and thyroxine (T4)] can regulate the food intake process (Lin et al., 1983; Ishii et al., 2003 & 2008; Kong et al., 2004). More importantly, regulation of the appetite might be depending on the local actions of THs in the central nervous system (CNS) (Amin et al., 2011).In addition, the activity of deiodinase 3 (D3) can regulate the food intake process and energy homeostasis through mediation the levels of THs (Bianco et al., 2002; Barrett et al., 2007). Activation of 5'-adenosinemonophosphate-activated protein kina se (AMPK; sensor of cellular energy home ostasis) in the arcuate nucleus (ARC) simulates the process of food intake (Minokoshi et al., 2008). Expression of G protein-coupled trace amine-associated receptor 1 (TAAR1) in the hypothalamus can regulate the activation of energy homeostasis (Dhillo et al., 2009).On the other hand, thyroid disorders in clinical reports have several disturbances actions on the body weight and appetite (Amin et al., 2011). In hypothyroidism, the levels of basal energy expenditure were decreased (Wolf et al., 1996), and the levels of weight gain were increased (Iossa et al., 1996; Manji et al., 2006). In opposite, the levels of basal energy expenditure were increased and the levels of weight gain were decreased during the hyperthyroidism (Alton and O’Malley, 1985; Pijl et al., 2001; Klieverik e al., 2009). Also, food deprivation may increase the risk of hypothyroidism; decrease the release of T3 and T4 in rodents (Légràdi et al., 1997) and human (Chan et al., 2003).

From the previous considerations, the fetal and neonatal development (appetite, food intake, metabolic rate and body weight) may depend on the activities of maternal HPTA. As well, the dysfunctions in the activities of HPTA may disturb the appetite and food intake, and delay the fetal and neonatal development. However, the physiological and developmental relevance of these defects remains unidentified. Enhancement our understanding of the action of the HPTA and THs in appetite and food intake may recognize novel goals about the anti-obesity agents. Additional investigations are essential to explore these interactions during the gestation and lactation periods. Further work is warranted to recognize the roles of maternal thyroid receptors (TR; α and β) on the neonatal appetite, food intake and metabolic rate.


References


  1. Ahmed, O.M., Abd El-Tawab, S.M., Ahmed, R.G., 2010. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I- The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions. Int. J. Dev. Neurosci. 28, 437-454.
  2. Ahmed, O.M., Abd El-Tawab, S.M.,Ahmed, R.G., 2010. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I- The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions.Int. J. Dev. Neurosci. 28, 437-454.
  3. Ahmed, O.M., Ahmed, R.G., 2012. Hypothyroidism. In A New Look At Hypothyroidism. Dr. D. Springer (Ed.), ISBN:978-953-51-0020-1), In Tech Open Access Publisher, Chapter 1, pp. 1-20.
  4. Ahmed, O.M., Ahmed, R.G., El-Gareib, A.W., El-Bakry, A.M., Abd El-Tawaba, S.M., 2012. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-The developmental pattern of neurons in relation to oxidative stress and antioxidant defense system. Int. J. Dev. Neurosci. 30, 517–537.
  5. Ahmed, O.M., El-Gareib, A.W., El-bakry, A.M., Abd El-Tawab, S.M., Ahmed, R.G., 2008. Thyroid hormones states and brain development interactions. Int. J. Dev. Neurosci. 26(2), 147-209. Review.
  6. Ahmed, R.G., 2011. Perinatal 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin exposure alters developmental neuroendocrine system. Food Chem. Toxicology, 49, 1276–1284.
  7. Ahmed, R.G., 2012a. Maternal-newborn thyroid dysfunction. In the Developmental Neuroendocrinology, pp. 1-369. Ed R.G. Ahmed. Germany: LAP LAMBERT Academic Publishing GmbH & Co KG.
  8. Ahmed, R.G., 2012b. Maternal-fetal thyroid interactions, Thyroid Hormone, Dr. N.K. Agrawal (Ed.), ISBN: 978-953-51-0678-4, In Tech Open Access Publisher, Chapter 5, pp. 125-156.
  9. Ahmed, R.G., 2013. Early weaning PCB 95 exposure alters the neonatal endocrine system: thyroid adipokine dysfunction. J. Endocrinol. 219 (3), 205-215.
  10. Ahmed, R.G., 2014. Editorial: Do PCBs modify the thyroid-adipokine axis during development? Annals Thyroid Res. 1(1), 11-12.
  11. Ahmed, R.G., 2015a. Chapter 1: Hypothyroidism and brain development. In advances in hypothyroidism treatment. Avid Science Borsigstr.9, 10115 Berlin, Berlin, Germany. Avid Science Publications level 6, Melange Towers, Wing a, Hitec City, Hyderabad, Telangana, India. pp. 1-40.
  12. Ahmed, R.G., 2015b. Hypothyroidism and brain developmental players. Thyroid Research J. 8(2), 1-12.
  13. Ahmed, R.G., 2015c. Editorials and Commentary: Maternofetal thyroid action and brain development. J. of Advances in Biology; 7(1), 1207-1213.
  14. Ahmed, R.G., 2016a. Gestational dexamethasone alters fetal neuroendocrine axis. Toxicology Letters, 258, 46–54.
  15. Ahmed, R.G., 2016b. Neonatal polychlorinated biphenyls-induced endocrine dysfunction. Ann. Thyroid. Res. 2 (1), 34-35.
  16. Ahmed, R.G., 2016c. Maternal iodine deficiency and brain disorders. Endocrinol. Metab.Syndr.5, 223.http: //dx.doi. org/ 10. 4172 /2161-1017.1000223.
  17. Ahmed, R.G., 2016d. Maternal bisphenol A alters fetal endocrine system: Thyroid adipokine dysfunction. Food Chem. Toxicology, 95, 168-174.
  18. Ahmed, R.G.,2017 a. Developmental thyroid diseases and GABAergic dysfunction. EC Neurology 8.1, 02-04.
  19. Ahmed, R.G., 2017b. Hyperthyroidism and developmental dysfunction.Arch Med. 9, 4.
  20. Ahmed, R.G.,2017 c. Anti-thyroid drugs may be at higher risk for perinatal thyroid disease. EC Pharmacology and Toxicology 4.4, 140-142.
  21. Ahmed, R.G., 2017d. Perinatal hypothyroidism and cytoskeleton dysfunction. Endocrinol MetabSyndr6, 271.doi:10.4172/2161-1017. 100 02 71
  22. Ahmed, R.G., 2017e. Developmental thyroid diseases and monoaminergic dysfunction. Advances in Applied Science Research 8(3), 01-10.
  23. Ahmed, R.G., 2017f. Hypothyroidism and brain development.J. Anim Res Nutr.2 (2), 13.
  24. Ahmed, R.G., 2017g. Antiepileptic drugs and developmental neuroendocrine dysfunction: Every why has A Wherefore.Arch Med 9(6), 2.
  25. Ahmed, R.G., 2017h. Gestational prooxidant-antioxidant imbalance may be at higher risk for postpartum thyroid disease. Endocrinol MetabSyndr 6, 279. doi:10.4172/2161-1017.1000279.
  26. Ahmed, R.G., 2017i. Synergistic actions of thyroid-adipokines axis during development. Endocrinol Metab Syndr 6, 280.doi: 10.4172/ 2161-1017.1000280.
  27. Ahmed, R.G., 2017j. Thyroid-insulin dysfunction during development. International Journal of Research Studies in Zoology 3(4), 73-75. DOI: http://dx.doi.org/10.20431/2454-941X.0304010.
  28. Ahmed, R.G.,2017k. Developmental thyroid diseases and cholinergic imbalance. International Journal of Research Studies in Zoology 3(4), 70-72. DOI: http: // dx.doi.org/ 10.20431/2454-941X.0304009.
  29. Ahmed, R.G., 2017l. Thyroid diseases and developmental adenosinergic imbalance. Int J Clin Endocrinol 1(2), 053-055.
  30. Ahmed, R.G.,2017m.Maternal anticancer drugs and fetal neuroendocrine dysfunction in experimental animals. Endocrinol Metab Syndr 6, 281.doi:10.4172/2161-1017.1000281.
  31. Ahmed, R.G., 2017 n. Letter: Gestational dexamethasone may be at higher risk for thyroid disease developing peripartum. Open Journal Of Biomedical & Life Sciences (Ojbili) 3(2), 01-06.
  32. Ahmed, R.G., 2017o.Deiodinases and developmental hypothyroidism. EC Nutrition 11.5, 183-185.
  33. Ahmed, R.G., 2017p.Maternofetal thyroid hormones and risk of diabetes. Int. J. of Res. Studies in Medical and Health Sciences 2(10), 18-21.
  34. Ahmed, R.G., 2017r.Association between hypothyroidism and renal dysfunctions. International Journal of Research Studies in Medical and Health Sciences 2(11), 1-4.
  35. Ahmed, R.G., 2017s.Maternal hypothyroidism and lung dysfunction. International Journal of Research Studies in Medical and Health Sciences 2(11), 8-11.
  36. Ahmed, R.G., 2017t.Endocrine disruptors; possible mechanisms for inducing developmental disorders. International journal of basic science in medicine (IJBSM) 2(4), xx-xx. (in press)
  37. Ahmed, R.G., 2017u.Maternal thyroid hormones trajectories and neonatal behavioral disorders. ARC Journal of Diabetes and Endocrinology 3(2), 18-21.
  38. Ahmed, R.G., 2018a. Maternal hypothyroidism and neonatal testicular dysfunction. International Journal of Research Studies in Medical and Health Sciences 3(1), 8-12.
  39. Ahmed, R.G., 2018b. Maternal thyroid disorders and bone maldevelopment: Are you ready to take risks for your offspring? J Pharma PharmaSci (JPPS) in press. DOI: 10.29011/2574-7711. 100058.
  40. Ahmed, R.G., Abdel-Latif, M., Ahmed F., 2015a.Protective effects of GM-CSF in experimental neonatalhypothyroidism. Interna tional Immunopharm acology 29, 538–543.
  41. Ahmed, R.G., Abdel-Latif, M., Mahdi, E., El-Nesr, K., 2015b. Immune stimulation improves endocrine and neural fetal outcomes in a model of maternofetal thyrotoxicosis. Int. Immunopharmacol. 29, 714-721.
  42. Ahmed, R.G., Davis, P.J., Davis, F.B., De Vito, P., Farias, R.N., Luly, P., Pedersen, J.Z., Incerpi, S., 2013a. Nongenomic actions of thyroid hormones: from basic research to clinical applications. An update. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, 13(1), 46-59.
  43. Ahmed, R.G., El-Gareib, A.W. 2014.Lactating PTU exposure: I- Alters thyroid-neural axis in neonatal cerebellum. Eur. J. of Biol. and Medical Sci. Res. 2(1), 1-16.
  44. Ahmed, R.G., El-Gareib, A.W., 2017.Maternal carbamazepine alters fetal neuroendocrine-cytokines axis. Toxicology 382, 59–66.
  45. Ahmed, R.G., El-Gareib, A.W., Incerpi, S., 2014. Lactating PTU exposure: II- Alters thyroid-axis and prooxidant-antioxidant balance in neonatal cerebellum. Int. Res. J. of Natural Sciences 2(1), 1-20.
  46. Ahmed, R.G.,El-Gareib, A.W., Shaker, H.M., 2018a.Gestational 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126) exposure disrupts fetoplacental unit: Fetal thyroid-cytokines dysfunction. Life Sciences 192, 213– 220.
  47. Ahmed, R.G., Incerpi, S., 2013. Gestational doxorubicin alters fetal thyroid–brain axis. Int. J. Devl. Neuroscience 31, 96–104.
  48. Ahmed, R.G., Incerpi, S., Ahmed, F., Gaber, A., 2013b. The developmental and physiological interactions between free radicals and antioxidant: Effect of environmental pollutants. J. of Natural Sci. Res. 3(13), 74-110.
  49. Ahmed, R.G.,Walaa G.H., Asmaa F.S., 2018b.Suppressive effects of neonatal bisphenol A on the neuroendocrine system. Toxicology and Industrial Health Journal (in press).
  50. Alton, S., O’Malley, B.P., 1985. Dietary intake in thyrotoxicosis before and after adequate carbimazole therapy; The impact of dietary advice. Clinical Endocrinology 23(5), 517–520.
  51. Amin, A., Dhillo, W.S., Murphy, K.G., 2011. The central effects of thyroid hormones on appetite.Journal of Thyroid Research 1-7.
  52. Barrett, P., Ebling, F.J.P., Schuhler, S., 2007. Hypothalamic thyroid hormone catabolism acts as a gatekeeper for the seasonal control of body weight and reproduction. Endocrinology 148(8), 3608–3617.
  53. Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J., Larsen, P.R., 2002. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 23(1), 38–89.
  54. Candelotti, E., De Vito, P., Ahmed, R.G., Luly, P., Davis, P.J., Pedersen, J.Z., Lin, H-Y., Incerpi, I., 2015. Thyroid hormones crosstalk with growth factors: Old facts and new hypotheses. Immun., Endoc.&Metab. Agents in Med. Chem., 15, 71-85.
  55. Chan, J.L., Heist, K., DePaoli, A.M., Veldhuis, J.D., Mantzoros, C.S., 2003. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. Journal of Clinical Investigation 111(9), 1409–1421.
  56. De Vito, P., Candelotti, E., Ahmed, R.G., Luly, P., Davis, P.J., Incerpi, S., Pedersen, J.Z., 2015.Role of thyroid hormones in insulin resistance and diabetes.Immun., Endoc.& Metab. Agents in Med. Chem., 15, 86-93.
  57. Dhillo, W.S., Bewick, G.A., White, N.E., 2009.The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes, Obesity and Metabolism 11(3), 251–260.
  58. El-bakry, A.M., El-Ghareeb, A.W.,Ahmed, R.G., 2010.Comparative study of the effects of experimentally-induced hypothyroidism and hyperthyroidism in some brain regions in albino rats.Int. J. Dev. Neurosci. 28, 371-389.
  59. El-Ghareeb, A.A., El-Bakry, A.M., Ahmed, R.G., Gaber, A., 2016.Effects of zinc supplementation in neonatal hypothyroidism and cerebellar distortion induced by maternal carbimazole. Asian Journal of Applied Sciences 4(04), 1030-1040.
  60. Incerpi, S., Hsieh, M-T., Lin, H-Y., Cheng, G-Y., De Vito, P., Fiore, A.M., Ahmed, R.G., Salvia, R., Candelotti, E., Leone, S., Luly, P., Pedersen, J.Z., Davis, F.B., Davis, P.J., 2014. Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3. Am. J. Physiol. Cell Physiol. 307, C150–C161.
  61. Iossa, S., Lionetti, L., Mollica, M.P., Barletta, A., Liverini, G., 1996.Thermic effect of food in hypothyroid rats. Journal of Endocrinology, vol. 148, no. 1, pp. 167–174.
  62. Ishii, S., Kamegai, J., Tamura, H., Shimizu, T., Sugihara, H., Oikawa, S., 2003. Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis. Neuroendocrinology 78(6), 321–330.
  63. Ishii, S., Kamegai, J., Tamura, H., Shimizu, T.,Sugihara, H., Oikawa, S., 2008. Triiodothyronine (T3) stimulates food intake via enhanced hypothalamic AMP-activated kinase activity. Regulatory Peptides 151(1–3), 164–169.
  64. Klieverik, L.P., Coomans, C.P., Endert, E., 2009. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 150(12), 5639–5648.
  65. Kong, W.M., Martin, N.M., Smith, K.L., 2004. Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology 145(11), 5252–5258.
  66. Légràdi, G., Emerson, C.H., Ahima, R.S., Flier, J.S., Lechan, R.M., 1997. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138(6), 2569–2576.
  67. Lin, M.T., Chu, P.C., Leu, S.Y., 1983. Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat. Neuroendocrinology 37(3), 206–211.
  68. Manji, N., Boelaert, K., Sheppard, M.C., Holder, R.L., Gough, S.C., Franklyn, J.A., 2006.Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clinical Endocrinology 64(2), 125– 128.
  69. Männistö, T., Mendola, P., Reddy, U., Laughon, S.K., 2013.Neonatal Outcomes and BirthWeight in Pregnancies Complicated by Maternal Thyroid Disease. American Journal of Epidemiology 1-10.
  70. Minokoshi, Y., Shiuchi, T., Lee, S., Suzuki, A., Okamoto, S., 2008.Role of hypothalamic AMP-kinase in food intake regulation. Nutrition 24(9), 786–790.
  71. Ogilvy-Stuart, A.L., 2002.Neonatal thyroid disorders.Arch Dis Child Fetal Neonatal Ed 87, F165–F171.
  72. Pijl, H., De Meijer, P.H.E.M., Langius, J.,2001. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability. Journal of Clinical Endocrinology and Metabolism 86(12), 5848–5853.
  73. Van Herck, S.L.J., Geysens, S., Bald, E., Chwatko, G., Delezie, E., Dianati, E., Ahmed, R.G., Darras, V.M., 2013.Maternal transfer of methimazole and effects on thyroid hormone availability in embryonic tissues.Endocrinol. 218, 105-115.
  74. Wolf, M., Weigert, A., Kreymann, G., 1996.Body composition and energy expenditure in thyroidectomized patients during short-term hypothyroidism and thyrotropin-suppressive thyroxine therapy. European Journal of Endocrinology 134(2), 168–173.